Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? - Wikidata - wikimedia - TriplyDB

Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?

Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?

http://www.wikidata.org/entity/Q44547846

about

Effect of Interval between Neoadjuvant Chemoradiotherapy and Surgery on Oncological Outcome for Rectal Cancer: A Systematic Review and Meta-Analysis Pathologic Assessment of Rectal Carcinoma after Neoadjuvant Radio(chemo)therapy: Prognostic Implications Risk factors for local recurrence following neoadjuvant chemoradiotherapy for rectal cancers Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial.Impact of neoadjuvant treatment on total mesorectal excision for ultra-low rectal cancers.Oncologic impact of pathologic response on clinical outcome after preoperative chemoradiotherapy in locally advanced rectal cancer.A pilot feasibility study of TNFerade™ biologic with capecitabine and radiation therapy followed by surgical resection for the treatment of rectal cancer Impression of prognosis regarding pathologic stage after preoperative chemoradiotherapy in rectal cancer.Oncologic outcomes of primary and post-irradiated early stage rectal cancer: a retrospective cohort study Magnetic resonance imaging (MRI) in rectal cancer: a comprehensive review Edematous and painful external hemorrhoids following intersphincteric resection for low rectal cancer Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy Sphincter-preserving surgery after preoperative radiochemotherapy for T3 low rectal cancers Short-term outcomes after laparoscopic surgery following preoperative chemoradiotherapy for rectal cancer Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy.Clinical practice guidelines for the surgical treatment of rectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO)Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy.Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection: a pooled analysis of 3,313 patients Pathologic response to neoadjuvant treatment in locally advanced rectal cancer and impact on outcome An observational study of extending FOLFOX chemotherapy, lengthening the interval between radiotherapy and surgery, and enhancing pathological complete response rates in rectal cancer patients following preoperative chemoradiotherapy.Is Pathologic Near-Total Regression an Appropriate Indicator of a Good Response to Preoperative Chemoradiotherapy Based on Oncologic Outcome of Disease?The clinicopathologic relevance and prognostic value of tumor deposits and the applicability of N1c category in rectal cancer with preoperative radiotherapy Is the pathological regression level of metastatic lymph nodes associated with oncologic outcomes following preoperative chemoradiotherapy in rectal cancer?Can we predict pathologic complete response before surgery for locally advanced rectal cancer treated with preoperative chemoradiation therapy?Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis.Predicting the response to preoperative radiation or chemoradiation by a microarray analysis of the gene expression profiles in rectal cancer.Gene expression profile is associated with chemoradiation resistance in rectal cancer.Outcomes in the surgical treatment of low rectal cancer: does neoadjuvant treatment equalize results?Adjuvant chemotherapy after neoadjuvant chemoradiation and curative resection for rectal cancer: is it necessary for all patients?Is the delayed surgery after neoadjuvant chemoradiation beneficial for locally advanced rectal cancer?Clinical significance of fibroblast growth factor receptor 2 expression in patients with residual rectal cancer after preoperative chemoradiotherapy: relationship with KRAS or BRAF mutations and MSI status.The impact of surgical diversion before neoadjuvant therapy for rectal cancer.Adjuvant Second-Dose Chemotherapy before Surgery for Patients with Locally Advanced Rectal Malignancy Is Not Beneficial: A Systematic Review and Meta-Analysis.Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer.Reduction in the size of enlarged pelvic lymph nodes after chemoradiation therapy is associated with fewer lymph node metastases in locally advanced rectal carcinoma.Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation.Preoperative intensified radiochemotherapy for rectal cancer: experience of a single institution.Long-term outcomes in patients with locally advanced rectal cancer treated with preoperative chemoradiation followed by curative surgical resection.Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study.Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.

P2860

Q26748798-EFBC5511-4537-48A0-9151-C68942F622BE Q26778222-0DEC2894-9C91-45C1-B5D9-1E00BD0BBC76 Q26853016-FC738847-880F-4735-A890-0FDFE0483270 Q33438899-5F993216-DA7C-4362-88DE-1E47F5B48142 Q33809299-8FB0EC22-1724-4F2A-8CB1-C0D25CB8BDE7 Q34789082-88F1F9C9-F4E1-47A9-869D-E869A2A5C4EF Q34803980-744A1275-8159-4CDA-A9CE-B952C4E3D1CD Q34932625-6D42E046-7E48-4044-B10C-0DFF20AEEF0A Q35171544-A692DAF4-2E4D-417F-B6F3-B8B4BE9C364F Q35675792-F2E47B8F-D21F-4491-A595-2B503B09F6B0 Q35700815-9A360A15-2289-4DCE-B055-574CF60E7B53 Q35814400-06B6CF39-E8F8-47BB-A1B9-A93461E3670F Q36084304-13190FD5-3187-445C-AB74-2BA8B6C0202F Q36377618-8822F3E6-08E0-449E-8FDD-6478387A7B06 Q36614764-940ABCF2-F92E-4075-9D92-F26171327C7A Q36723979-424E1520-DA97-4C4F-A426-0AE74FC6D83E Q36822151-9513FB56-34F0-4FAF-8B3F-319C83DE97E8 Q37119089-9458D71F-41C6-44E6-BB77-E313EAFC3931 Q37131682-48328A54-CAC4-47CA-AF64-B7061A8291C9 Q37173767-6E54483F-B5BC-4E5B-8901-CA17080E8C49 Q37328335-2931F1B5-4C9A-4862-85BA-E190B217C43B Q37688901-66139E32-208F-437B-A818-F617CC871741 Q37705840-609E55FE-2BA4-4F34-9FDD-124DA98CBDF1 Q37955677-230E501C-F082-496B-8BC8-DEF5957493AC Q37995506-A29CDE2E-2997-49D6-A1D0-0A225092EC13 Q38019396-499F0558-2779-47DD-8F81-8256FBDC7671 Q38137324-6765FA19-A307-4472-94F4-3A33C929A87A Q38236794-5E5CA4B6-C06F-4DDD-823D-048BC77E77DA Q38285536-2F0ABE41-81FC-47FB-9280-0B3DB3C54824 Q39413499-DB15068A-7096-457A-AA6C-57B3081F5D06 Q40036023-3D01CB7F-6AA5-4E4F-A526-B483A70D28D7 Q40939163-5F8F0E2F-904E-4D98-9EB4-591E6258A4FC Q41403148-D5D1C15D-79E5-44E2-B103-5A20A9559885 Q41692918-59DCDDE5-5804-4A19-8042-F1BE18C225EF Q44243072-278801CF-5B69-4F0A-8DF9-48251D343DD1 Q44728910-B059394D-555A-414B-9150-61AAD0BC7F64 Q44801406-04997571-9FDC-42C4-8A1B-20A226900064 Q45241659-8C7647F6-96C9-4BF9-A29B-3614749A4BEA Q46156144-468E8B40-B51E-4142-B8CE-5E3489D4D77D Q46883395-6AB48E31-8568-4E2A-A041-8D4450C4A35F

P2860

Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?

http://www.wikidata.org/entity/Q44547846

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Is final TNM staging a predict ...... rative chemoradiation therapy?

@en

Is final TNM staging a predict ...... rative chemoradiation therapy?

@nl

type

label

Is final TNM staging a predict ...... rative chemoradiation therapy?

@en

Is final TNM staging a predict ...... rative chemoradiation therapy?

@nl

prefLabel

Is final TNM staging a predict ...... rative chemoradiation therapy?

@en

Is final TNM staging a predict ...... rative chemoradiation therapy?

@nl

P1433

Q44547846-60E0B885-47A6-4367-B6FB-49001E8C6832

P1476

Q44547846-E8EF86AA-F047-4F0A-BC53-D0AB7B9B75CC

P2093

Q44547846-105A494F-89E7-4E17-91C4-0151A2E6756E

Q44547846-10C1E062-1228-4060-B8C8-495DAE3EC61D

Q44547846-2E094C8B-7D5C-4B2B-8181-2B8A4E1110F3

Q44547846-3917D50B-B314-441C-B2E3-34FAA118A70A

Q44547846-65C3AFD7-EA89-445A-87EA-B0D38A8A140D

Q44547846-E5BD68CE-491B-4B83-99C2-7802AC119EB7

Q44547846-EF6FA8DC-B4B9-49A2-A669-F5435528FCB9

Q44547846-FF6BC2AE-6027-4E4B-B191-F72DB76D1593

P2860

Q44547846-3CFC1316-8F14-41D4-B8E0-657F69E6856C

Q44547846-581AB799-549E-4110-9552-5DE712F45E48

Q44547846-A8871E01-67CF-4BBB-87B4-F92519934541

P2888

Q44547846-1880DE78-DCFD-4582-A594-823F768B46C1

P304

Q44547846-76D826AF-D96B-4C43-AFD1-3AD15EA71BB6

P31

Q44547846-59A7ECE6-54B6-4ACA-A51F-E6919EBD3D9E

P356

Q44547846-61FC8E13-3DD8-42E0-A1E1-744B0248E39A

P433

Q44547846-72FD7CEB-37B0-4465-9FC2-144D10FC9D78

P478

Q44547846-EE429813-6264-445C-A40D-E9CC939928B3

P577

Q44547846-41A30782-DB8E-4DEA-97E1-432C841DE4F9

P6179

Q44547846-366881CA-85B1-4E61-90CA-A01BB5756F23

P698

Q44547846-D4FE31DC-2866-4BAB-8826-7CA099F0B5FE

P921

Q44547846-7B73A306-CEB4-481F-B575-1DF0363C6AB5

P356

S10434-007-9471-Z

P1433

Annals of Surgical Oncology

P1476

Is final TNM staging a predict ...... rative chemoradiation therapy?

@en

P2093

Cheng-Fang Horng

http://www.w3.org/2001/XMLSchema#string

Chung-Ming Chen

http://www.w3.org/2001/XMLSchema#string

James Jer-Min Jian

http://www.w3.org/2001/XMLSchema#string

Li-Jen Kuo

http://www.w3.org/2001/XMLSchema#string

Mei-Ching Liu

http://www.w3.org/2001/XMLSchema#string

Tsun-I Cheng

http://www.w3.org/2001/XMLSchema#string

Wei-Tse Fang

http://www.w3.org/2001/XMLSchema#string

Yih-Lin Chung

http://www.w3.org/2001/XMLSchema#string

P2860

Epidermal growth factor receptor is a predictor of tumor response in locally advanced rectal cancer patients treated with preoperative radiotherapy.

The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer.

Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.

P2888

s10434-007-9471-z

P304

2766-2772

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-007-9471-Z

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1009076310

http://www.w3.org/2001/XMLSchema#string

P698

17551794

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy